Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 48 of 48 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company 908 Devices Inc. | Activity: Research and Development | Company Description 908 Devices develops and makes chemical analysis products such as handheld chemical detection tools, compact analyzers and separation devices. | Location Carrboro |
| |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill |
| |
Company AnelleO | Activity: Research and Development | Company Description AnelleO is developing a 3D-printed intravaginal ring that can be used for treating infertility and a wide range of other women's health conditions. | Location Chapel Hill |
| |
Company Areteia Therapeutics Inc. | Activity: Research and Development | Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. | Location Chapel Hill |
| |
Company Assure Technologies LLC | Activity: Research and Development | Company Description Assure Technologies has developed the Precynge (a precise syringe) for accurate measurement of medication dosage, which will especially address medication errors common in pediatrics. | Location Chapel Hill |
| |
Company Auration Biotech Inc. | Activity: Research and Development | Company Description Auration Biotech is developing novel therapeutics for ear, nose and throat diseases. | Location Chapel Hill |
| |
Company Bio 54 LLC | Activity: Research and Development | Company Description Bio 54 is developing a hand-held drug delivery device for patients to treat external bleeding from minor wounds in anticoagulant patients. | Location Chapel Hill |
| |
Company BioKier Inc. | Activity: Research and Development | Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. | Location Chapel Hill |
| |
Company BioRxn LLC | Activity: Research and Development | Company Description BioRxn develops NMR-based metabolomic technology, including bioreactor and artificial liver systems, for non-invasive monitoring of metabolic biomarkers. BioRxn also provides conventional metabolomic services. | Location Chapel Hill |
| |
Company BMPolytech LLC | Activity: Research and Development | Company Description BMPolytech is developing a new class of synthetic materials, tissue-mimetic Brush-like Polymer Networks, for use in advanced biomedical devices, such as implants, drug delivery devices and wound care. | Location Chapel Hill |
| |
Company Boundless Science LLC | Activity: Research and Development | Company Description Boundless Science develops a device for heart and lung oxygenation as a safer alternative to ECMO. | Location Chapel Hill |
| |
Company Caeregen Therapeutics LLC | Activity: Research and Development | Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. | Location Chapel Hill |
| |
Company Cell Spinpod LLC | Activity: Research and Development | Company Description Cell Spinpod develops and sells rotating suspension cell culture devices. Cell spinpods are miniature rotating bioreactors that keep cells, spheroids, or microorganisms in 3D suspension culture. | Location Chapel Hill |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company Citranvi Biosciences LLC | Activity: Research and Development | Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. | Location Chapel Hill |
| |
Company Clarus Biologics Inc. | Activity: Research and Development | Company Description Clarus Biologics is developing innovative vaccine and immunotherapeutic products using a novel and proprietary self-amplifying mRNA delivery and viral particle technology platform. Its first innovation is a vaccine VLP that enhances the effectiveness, efficiency and availability of vaccines. | Location Chapel Hill |
| |
Company Clue Genetics | Activity: Research and Development | Company Description Clue Genetics analyzes microbial genomes from fungi to identify novel active compounds that may have human health, pest resistance and environmental applications. | Location Hillsborough |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill |
| |
Company ENTEX Technologies Inc. | Activity: Research and Development | Company Description ENTEX Technologies provides advanced biological and filtration wastewater treatment that can be customized for various industries. | Location Chapel Hill |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill |
| |
Company Integrated Precision Metabolomics | Activity: Research and Development | Company Description Integrated Precision Metabolomics is developing a new type of mass spectrometer instrumentation and related software that will enable easier metabolomics analysis by end users. | Location Chapel Hill |
| |
Company Jurata Thin Film Inc. | Activity: Research and Development | Company Description Jurata Thin Film is developing an oral, thin film vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes inexpensively, without refrigeration. | Location Chapel Hill |
| |
Company Kalia Health | Activity: Research and Development | Company Description Kalia Health develops home-based early detection tests for pregnancy complications like preeclampsia and eclampsia for use in low-resource settings. | Location Chapel Hill |
| |
Company Krenitsky Pharmaceuticals Inc. | Activity: Research and Development | Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. | Location Chapel Hill |
| |
Company LVM Biosciences Inc. | Activity: Research and Development | Company Description LVM Biosciences develops therapeutics for epilepsy, stroke, anxiety, migraine, and pain. | Location Chapel Hill |
| |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough |
| |
Company Mizar Therapeutics | Activity: Research and Development | Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. | Location Chapel Hill |
| |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough |
| |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill |
| |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill |
| |
Company Qura Therapeutics LLC | Activity: Research and Development | Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. | Location Chapel Hill |
| |
Company READDI Inc. | Activity: Research and Development | Company Description Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a public-private partnership that develops broad-spectrum antiviral therapies for COVID-19 and other emerging viral threats. | Location Chapel Hill |
| |
Company Renovion Inc. | Activity: Research and Development | Company Description Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. | Location Chapel Hill |
| |
Company SIF Biopharma LLC | Activity: Research and Development | Company Description SIF Biopharma develops new therapies in the areas of regenerative medicine and cancer. | Location Chapel Hill |
| |
Company Sonokine Bioscience Inc. | Activity: Research and Development | Company Description Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies. | Location Chapel Hill |
| |
Company SonoVascular Inc. | Activity: Research and Development | Company Description SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to more effectively treat deep vein thrombosis and pulmonary embolism. | Location Chapel Hill |
| |
Company Speedwell Bio LLC | Activity: Research and Development | Company Description Speedwell Bio develops novel molecular assays and reagents for research and clinical diagnostics. | Location Chapel Hill |
| |
Company Ternalys Therapeutics Inc. | Activity: Research and Development | Company Description Ternalys develops technology that facilitates microRNA replacement therapy to treat glioblastoma and other cancers. | Location Chapel Hill |
| |
Company TheraSplice | Activity: Research and Development | Company Description TheraSplice is developing a precision oncology platform and products. The company has several targets under development in prostate, lung, breast, and liver cancer with the goal of initiating biomarker stratified clinical trials. | Location Chapel Hill |
| |
Company TheraVida Inc. | Activity: Research and Development | Company Description TheraVida is developing a treatment for primary focal hyperhidrosis. | Location Chapel Hill |
| |
Company TransChromix LLC | Activity: Research and Development | Company Description TransChromix is developing novel therapeutic inventions for chronic inflammation-associated diseases, such as Type 1 diabetes and Alzheimer's disease. | Location Chapel Hill |
| |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |